Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Dr Simona Valletta, a postdoctoral research in MRC MHU, who was awarded an Intermediate Research Fellowship from the Kay Kendall Leukaemia Fund.

Profile photograph of Dr Simona Valletta

Dr Valletta’s fellowship will be based in the Nerlov group (Radcliffe Department of Medicine) and will explore the effects of the ageing bone marrow microevironment in the prognosis of acute myeloid leukaemia (AML).

AML is an aggressive form of leukaemia and one of the most common forms of acute leukaemia in adults. Disease relapse and multidrug resistance increase dramatically with age, particularly over the age of 65.

Previous research has examined how ageing affects haematopoietic stem cells, including how it may skew their differentiation to particular lineages or limit their repopulation potential following treatments such as bone marrow transplant. However, it is unclear how the bone marrow microenvironment where these cells reside is itself affected by age. The stem niche has a crucial role in maintaining and regulating normal haematopoiesis.

Dr Valletta’s research will specifically examine how the ageing microenvironment influences Leukaemic Initiating Cells, cells with stem cell-like properties that are able to initiate leukaemia, ultimately leading to AML. The project hopes to understand how the niche influences Leukaemic Initiating Cells’ behavior and how they contribute to increased chemotherapy resistance and disease relapse in elderly patients. Ultimately the researchers hope to identify new drug targets that may be able to counteract these effects and improve treatments for AML patients.

Similar stories

T cell Immunotherapy animation launched

A new animation explores work by the Chakraverty Group, Vyas Group, and Professor Borrow from the Jenner Institute.

New study reveals role of lymphatic system in bone healing

It was previously assumed that bones lacked lymphatic vessels, but new research from the Kusumbe Group published in Cell not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.

Irene Roberts delivers Ham-Wasserman Lecture

Presented at the American Society of Hematology Annual Meeting, the award and lectureship recognises individuals from outside the United States who have made significant contributions to Haematology.

Anjali Kusumbe receives Women in Cell Biology Early Career Medal

Founded in 2015 to mark the 50th anniversity of the founding of the British Society for Cell Biology, the award recognises outstanding early career biologists.

Asger Jakobsen receives ASH-BSH Abstract Achievement Award

Dr Jakobsen, a Clinical Research Fellow and DPhil student from the Vyas Group has received the award from the American Society of Hematology and the British Society of Haematology.

New Studentship honours Enzo Cerundolo

A new Studentship has been announced in memory of the late MRC HIU Director and MRC WIMM Group Leader.